Development of drug use indicators for epilepsy. by Ball, D.E. & Taderera, A.
Vol. 44. Nos. 11/1.
I
II CONTENTS
ORIGINAL ARTICLES
Oestrogen and progesieronc receptors in Nigerian 
breast cancer relationship to tumour 
histopathologv and survival of patients.................
A cost-ettective particle agglutination assay to 
detect viral antibodies in dried blood spots 
— a simple solution to HIV and HCV screening..
November-December 2003
WSt
OF Ikpatt. R Ndoma-Egba . 1 1 ~>
J J Jourbert, J B Dewar, J Weinberg,
M De Beer. J S Parker. A D Steele....................  127
Epidemiology and mortality of burns at the 
Queen Elizabeth Central Hospital Blantyre, Malawi
OO Komolafe. J James, M Makoka 
L Kalongeolera ............................................. ......  130
Development of drug use indicators for epilepsy DE Ball. A Taderera..................................... ......  134
CASE REPORT
Erythrocytosis due to autonomous erythropoietin 
production by a hypernephroma............................
'
EDITORIAL
Forum of African Medical Editors (FAME)........
CONTINUED HEALTH EDUCATION 
FOR THE PRACTITIONER 
Management of snake b ites ....................................
NOTES AND NEWS
List of reterccs for 2003 .........................................
P Jacobs.................................................................. 138
- A-.- • i p
Gl Muguti..............................................................  140
Instructions to Authors
Gl Muguti................................................
Central African Journal of Medicine .... 
Central African Journal of Medicine ....
m
Development of drug use indicators for epilepsy
DE BALL, A TADERERA
Abstract
Objective: To develop and use drug use indicators for epilepsy management.
Design: Descriptive prospective (outpatient) and retrospective (inpatient) drug use indicator survey. 
Setting: Parirenyatwa Hospital epilepsy clinic and medical wards.
Subjects: Random sample of 35 cases of status epilepticus and a prospective series of 31 patients attending 
the epilepsy clinic.
Interventions: Indicators of drug use and patient care were developed and measured against national standard 
treatment guidelines (EDLIZ). Stock levels of all anti epileptic drugs (AEDs) were determined.
Main Outcome Measures: Adherence to EDLIZ; utility of indicator measures.
Results: For inpatients, average length of hospital stay was 8.7 days, with 60.0% adherence to EDLIZ. Less 
than half of the patients had an EEG performed and one third had an AED blood level measured. On discharge, 
patients were prescribed an average of 1.1 AEDs. Outpatient indicators showed good adherence to EDLIZ 
(89.2%) and an average of 1.2 AEDs drugs per prescription. Only 56.4% of prescribed drugs were actually 
dispensed. Most knew the dose and frequency of their medication but only 71.4% were aware of the expected 
duration of therapy.
Conclusions: The use of the indicators provided a snapshot of epilepsy management and indicated that 
problems may exist in the use of EEGs and in drug supply at Parirenyatwa Hospital. Sensitivity of the
indicators to change and across levels of care still needs to be determined.
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Introduction so as to make comparisons within an institution over time, 
to compare different institutions, to allow for assessment 
of the impact of interventions and to use as a supervisory 
tool so as to highlight problems in prescribing or drug use 
patterns. Indicators have been developed by the World 
Health Organisation (WHO) to assess drug use at clinic or 
out patient facilities2 examining patient care e.g. average 
consultation time, prescribing e.g. average number of
Rational drug use implies using the correct drug at the 
correct dose in the correct patient for the correct period of 
timed Irrational use of drug leads to wasted resources and 
poor quality treatment with attendant increases in morbidity 
and mortality. Means to monitor drug use and factors 
which impact on drug use in an objective way are required
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drugs per prescription, and facility indicators e.g. 
availability of key drugs. The measurement of indicators is 
intended to be a simple means of monitoring drug use 
behaviour using, as much as possible, routinely collected 
data. They are intended to be used as part of clinical audit 
to monitor the quality of care being provided to patients, 
and also to assist in identifying potential problems which 
may require more in-depth assessment. However, the 
existing drug use indicators are generic and do not deal 
with specific diseases. In addition, there are no indicators 
for hospital inpatients or hospital departments where the 
results could be used by the administration in policy 
development and drug management.' There is need to- 
develop drug use indicators-for evaluation of hospital 
prescribing patterns in selected health problems.
Epilepsy is a relatively common neurological condition 
with a prevalence of between 0.4% and 0.75% in developed 
countries3 and perhaps up to 5% in some developing 
countries.4 The management of epilepsy has been 
intensively studied both in terms of diagnosis, acute and 
long term treatment. Almost three quarters of patients can 
have their seizures- controlled on monotherapy5 and the 
titration of dosages to seizure control and side-effects is 
well recognised. Internationally, quality Of care standards 
have been developed for the treatment of epilepsy and in 
Zimbabwe, there are standard treatment guidelines for the 
management of epilepsy including drug therapy (EDLIZ).6 
Thus, epilepsy lends itself to audit through the measurement 
of indicators since there are standards for comparison. The 
main objective of this study was to develop and measure 
disease-specific drug use indicators for epilepsy 
management at in patient and out patient settings.
Materials and Methods
Possible indicators of the care of epilepsy patients were 
devised using a theoretical basis for both in patient and out 
patient scenarios. The WHO core and complementary 
prescribing indicators were used for some of the measures.2 
These indicators are shown in Table I, together.with a brief 
explanation where necessary. The indicators were measured 
at Parireny atwa Hospital, Harare, Zimbabwe, a large referral 
and teaching hospital.
The in patient indicators were measured retrospectively 
using a sample of 35 cases of status epilepticus selected 
from all such records for the period 1 January 1998 to 31 
December 1999 (total 156 cases; 22.4% sample) using 
random systematic sampling. The labourious nature of 
record retrieval precluded validation of the hospital coding 
system (based on the International Classification of Diseases 
9lh Revision),7 but all records retrieved were of status 
epilepticus based on the clinical picture made up of both 
physician and nursing notes. No other exclusion or inclusion 
criteria were applied.
Out patient indicators were measured prospectively on 
31 consecutive patients at the Epilepsy Clinic, Parireny atwa 
Hospital during the period 3 January to 14 February 2000.
Table /.: Proposed epilepsy inpatient and outpatient drug 
use indicators\measured in the study.
Inpatient indicators
• Average number of AEDs prescribed on discharge
• Percent of AEDs prescribed by generic name
• Percent of prescribed AEDs present in essential drug list (EDLIZ)
• Percent of patients with blood level taken for any reason during hospital stay 
■ Percent of patients with antiepileptic drug assay performed during hospital
stay
• Percent of patients with an EEG done during hospital stay
• Percent adherence to standard treatment 'guidelines
• Average- length of hospital stay
Outpatient indicators
• Average number of drugs per prescription
• Percent AEDs prescribed by generic name
• Percent prescribed AEDs present in essential drugs list (EDLIZ)
• Average consultation time (time between patient entering .and leaving 
consultation room)
• Average dispensing time (total from receipt of prescription to patient leaving)
• Average dispensing counselling time (time taken when handing over 
prescription)
• Percent of patients satisfied with care
• Percent of patients who have returned for review
• Percent of patients with uncontrolled seizures
• Percent of patients with an EEG performed in the past year
• Percent of patients with AED blood level taken in past year
• Percent patients members of epilepsy patient support group
• Percent adherence to standard treatment guidelines
• Percent prescribed drugs actually dispensed
• Percent adequate labelling of dispensed medication
• Percent patient knowledge of drug dose, frequency and duration of therapy
This clinic handles referred new patients for full diagnostic 
workup, patients .with problematic or resistant-epilepsy as 
well as some well-controlled patients for review. Amember 
of the Epilepsy Support Foundation of Zimbabwe, a patient 
support group, is usually present at the clinic for 
consultation.
For generic prescribing, any abbreviations or incomplete 
drug names were not considered to be the generic name, 
whilst for valproic acid, the names valproate, and sodium 
valproate were also considered acceptable generic names.
The Zimbabwe standard treatment guidelines set out in 
EDLIZ 19946 were used for comparison. Drug management 
of epilepsy is based on monotherapy starting with 
phenobarbitone as drug of first choice, followed by 
phenytoin and carbam azepine respectively i.e. 
phenobarbitone first, if ineffective change to phenytoin 
and then to carbamazepine. Sodium valproate may be 
prescribed by specialists. Ethosuximide was indicated for 
absence seizures. For status epilepticus, oxygen plus i.v. 
dextrose 50% plus i.v. diazepam or i.v. phenobarbitone or
i.m. paraldehyde or i.v. phenytoin is the prescribed 
treatment. In terms of adherence to the standard treatment 
guidelines (STGs), the use of any of the alternatives as a 
single drug was considered acceptable since it was not 
possible to accurately determine if the drugs had been 
commenced in the order specified in the STGs. The drug 
had to be used at the dose recommended in the STGs to 
meet the criteria of adherence.
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The stock levels of all AEDs were assessed at the main 
pharmacy in the hospital since availability can impact op 
prescribingpattcrns. Both dispensary shelves as well as the 
main store were examined for the drugs which were 
reported as either in or out of stock. This check was 
performed only at the start of the study period. Permission 
to conduct the study was received from the Hospital 
Medical Superintendent.
Sample Size.
According to WHO drug use indicator methodology, a 
sample of 30 drug use encounters at an institution provides 
adequate power to provide a cross sectional overview of 
drug use at that facility.-1
Results
Of the six oral AEDs which are recommended in EDLIZ 
1994 for the management of epilepsy, only three 
phenobarbitone, carbamazepine and sodium valproate were 
in stock at the hospital’s main pharmacy, with phenytoin, 
clonazepam and ethosuximide out of stock. Of the drugs 
recommended for status epilepticus, only diazepam 
injection and dextrose 50% i.v. fluid were available with 
parenteral phenobarbitone, phenytoin and paraldehyde not 
in stock. The indicator values measured are shown in 
Tables II and III
Table II: Inpatient indicators for epilepsy care at 
Parirenyatwa Hospital (n = 33).
Indicator Value
Ave number of AEDs prescribed at discharge 1.1
% AEDs prescribed by generic name 100.0
% AEDs prescribed in EDLIZ 97.2
Ave length hospital stay (days) 8.7
% adherence to STGs 60.0
% patients with EEG 43.3
% patients with blood sample (any reason) 66.7
% patients with serum AED assay ■ 36.7
AED -Antiepileptic drug.
EEG — Electroencephalogram.
EDLIZ — Essential Drugs List for Zimbabwe.
STGs — Standard treatment guidelines.
Inpatient Indicators.
Of the 35 cases, two patients died before discharge and 
were not incorporated into the prescribing indicators or the 
length of hospital stay (Table II). The average length of 
hospital stay was 8.7 days, with 60.0% adherence to 
standard treatment guidelines for drug management. Less 
than half of the patients had an EEG performed during their 
hospitalisation and just over one third had a blood sample 
drawn for serum assay of antiepileptic drugs. On discharge, 
patients were prescribed an average of 1.1 AEDs drugs. 
Outpatient Indicators.
In general, there was good adherence to standard treatment 
guidelines (89.2%) with complete generic prescribing and 
an average of 1.2 AEDS drugs per prescription (Table III). 
However, only 56.4% of prescribed drugs were actually 
dispensed but 77.4% of'patients were satisfied with the 
care they received. Over 85 % of patients were returning for
Table III: Out patient indicators of epileptic drug use at 
Parirenyatwa Hospital (n = 31)
Indicator Value
Ave number of AEDs per prescription 1.2
% AEDs prescribed by generic name 100.0
% AEDs prescribed in EDLIZ 97.1
% adherence to STGs 89.2
Ave consultation time (min) 6.6
Ave dispensing time (s) 111
Ave dispensing counselling time (s) 11.5
% patients satisfied with care 77.4
% review patients 87.1
% patients with uncontrolled seizures 12.9
% patients members of support group 80.7
% patients with AED assay in past year 22.6
% patients with EEG in past year 80.7
% prescribed drugs actually dispensed 56.4
% drugs correctly labelled:
• drug name 100.0
• strength 100.0
• quantity 95.5
• date 81.8
• patient's name 50.0
• dose 100.0
• facility name 36.4
% patients with knowledge of:
• drug dose 93.6
• dose frequency 87.1
• duration of treatment 71.0
review with 12.9% having uncontrolled seizures. Most 
(80.7%) had had an EEG performed over the past year. 
About 90% of patients knew the dose and frequency of 
their medication but oniy 71.4% were aware as to how long 
they would have to take the drugs for. Labelling of 
medication containers was acceptable apart from the name 
of the patient (50% of labels) and the facility name (36.4%). 
Most patients were members of a patient support group.
In general, data for all inpatient indicators were easily 
extracted from the medical records and the time required 
would be markedly reduced if only a few priority indicators 
were to be measured. Out patient indicators required a bit 
more time due to the need for observations and interviews. 
However, the time would also be shortened if only a few 
core indicators were to be measured.
Discussion
Indicator studies were initially developed as a tool for 
rapid assessment of drug use2 where it is assumed that the 
diagnosis made is correct. As such they should be relatively 
quick and easy to measure using routinely gathered data 
where available. Indicators for measurement of drug use in 
general have been previously developed2 but they are in the 
main unsuitable for the assessment of prescribing within a 
particular disease state. The aim of this study was to 
develop a more specific set of indicators, based on the 
WHO core and complementary indicators, to be used for 
investigation of drug use within the management of 
epilepsy. No differentiation was made between adult and
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paediatric patients in this study. Whilst this may add a 
degree of variability into the results, it does not detract 
from the potential usefulness of the indicators, which 
could be limited to study particular age groups in practice. 
Inpatient Indicators.
Whilst not possible to validate that all of the 156 cases 
identified were status epilepticus there is no reason to 
believe that this introduces bias into the results since all the 
selected cases did represent status according to the clinical 
picture.
All of the proposed indicators for epilepsy in patients 
were able to be measured with'relative ease retrospectively 
from the patient case notes. A number of interesting issues 
arise from the indicators which were measured in this 
study. Less than half of the patients had received an EEG 
and only two thirds had had a blood sample drawn for any 
reason e.g. to measure blood glucose or AED drug levels. 
One would normally expect higher levels of use of the EEG 
and blood sampling to exclude non-epileptic causes of 
seizures8 although the resource limitations of a developing 
country must be taken into account.g It is possible that in 
some cases the physicians were aware of the past history of 
epilepsy in these patients and assumed a diagnosis of status 
epilepticus. The low level of blood sampling may also 
reflect poor laboratory backup where results are slow to 
come back to the wards so they are of little consequence on 
the clinical intervention.
The average number of drugs on discharge is low 
suggesting that attempts are made to maintain patients on 
monotherapy even after an episode of status. Generic 
prescribing is high but adherence to standard treatment 
guidelines was relatively low, something which should be 
investigated further to determine the reasons for this. 
Outpatient Indicators.
A recent survey of drug use in a variety of public health 
institutions in Zimbabwe (Zimbabwe Public Sector 
Survey)10 found the average number of drugs to be 1.8 with 
90% prescribing by generic name. One would normally 
expect the average number of drugs in a referral hospital to 
be higher than this figure, which also includes primary care 
centres. However, compared to this data, the average 
number of drugs per prescription in this study was low 
suggesting that monotherapy is being adhered to in the 
main whilst generic prescribing was somewhat higher. 
This view is supported by the adherence to standard 
treatment guidelines which was around 90% of cases, but 
it is also possible that the low average number of drugs was 
due to many being out of stock.
In terms of patient care indicators, The Zimbabwe Public 
Sector Survey found patient knowledge of the dosing of 
their drugs to be around 90% and of the duration of therapy 
79%, both of which are similar to the findings of this study. 
However, one would wish people with epilepsy to have a 
better understanding of how long they will be expected to 
take their medication due to the chronic nature of the 
disease and the serious consequences if they do not adhere 
to prescribed therapy.
The average consultation time (6.6min) was sjigiim 
higher than that reported in the Zimbabwe Public Sector 
Survey (5.1 min) and is rather short when allowing for 
adequate history taking and examination. However, the 
caseload and the fact that the majority of patients were 
simply attending for review should be taken into account. 
The dispensing .counselling time was very short (11.5s) 
and barely enough time to give instructions on how to take 
the medicines. In spite of this, about 90% of patients knew 
the dose and dosing frequency. This could be attributed to 
the fact that many patients were attending for review and 
had taken the drugs before. The level of adequate labelling 
may also have overcome adverse consequences of the 
short dispensing counselling time.
It is of concern that j ust over 50% of the prescribed drugs 
had been dispensed due to poor stock levels. In spite of this, 
only 12% of patients had uncontrolled seizures but this 
may relate more to the availability of drugs in the previous 
month. Some patients will be able to afford purchasing 
their drugs from private pharmacies but the majority would 
rely on the pharmacy within the hospital. Over three 
quarters of patients reported that they were satisfied with 
the care they were receiving.
Conclusion
This study has described the development of drug use 
indicators for epilepsy for use in both in and out patient 
settings which will allow for the audit and supervision of 
epilepsy care services. Not all indicators need to be measured 
as this will depend on the purpose of the monitoring of 
care. As shown above, they are able to provide an insight 
into the management of epilepsy patients and to indicate 
areas where problems may exist and which require more 
detailed study. For their full interpretation there needs to be 
data collection on a serial basis with prior studies for 
comparison, both nationally and internationally. The next 
step will be assessing these indicators at other hospitals 
and levels of care to determine their sensitivity to change.
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